Biomarkers for targeted therapy selection in non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Paz-Ares, L. [1 ,2 ]
机构：
[1] Hosp Univ Virgen del Rocio, Barcelona, Spain
[2] Inst Biomed Sevilla, Seville, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72606-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [31] Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
    Guo, Shicheng
    Yan, Fengyang
    Xu, Jibin
    Bao, Yang
    Zhu, Ji
    Wang, Xiaotian
    Wu, Junjie
    Li, Yi
    Pu, Weilin
    Liu, Yan
    Jiang, Zhengwen
    Ma, Yanyun
    Chen, Xiaofeng
    Xiong, Momiao
    Jin, Li
    Wang, Jiucun
    Clinical Epigenetics, 2015, 7 : 2 - 9
  • [32] Vaccines as adjuvant therapy for non-small cell lung cancer (NSCLC)
    Butts, Charles
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S220 - S221
  • [33] STATUS OF IMMUNE THERAPY IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Parums, D. V.
    DRUGS OF THE FUTURE, 2014, 39 (07) : 469 - 477
  • [34] Multi-targeted therapy in recurred and advanced Non-Small Cell Lung Cancer (NSCLC) in Thailand
    Prempree, Thongbliew
    Wongpaksa, Charlorboon
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S705 - S706
  • [35] Targeted therapy in advanced non-small cell lung cancer (NSCLC): Where do we stand?
    Azim, Hatem A., Jr.
    Ganti, Apar Kishor
    CANCER TREATMENT REVIEWS, 2006, 32 (08) : 630 - 636
  • [36] Rational selection of biomarkers to help direct erlotinib treatment for advanced non-small cell lung cancer (NSCLC)
    Borgia, Jeffrey A.
    Frankenberger, Casey
    Basu, Sanjib
    Rouhi, Omid
    Fidler, Mary J.
    Batus, Marta
    Fhied, Cristina L.
    Dalovisio, Andrew P.
    Lie, Wen-Rong
    Maheshwari, Reeti
    Hayes, David
    Coon, John
    Bonomi, Philip
    CANCER RESEARCH, 2011, 71
  • [37] Biomarkers and targeted systemic therapies in advanced non-small cell lung cancer
    Kumar, Mukesh
    Ernani, Vinicius
    Owonikoko, Taofeek K.
    MOLECULAR ASPECTS OF MEDICINE, 2015, 45 : 55 - 66
  • [38] Non-small cell lung cancer: from targeted therapy to tailored therapy
    Malgieri, Simona
    Feliciano, Salvatore
    Bosso, Davide
    Federico, Piera
    Palmieri, Giovannella
    De Placido, Sabino
    Di Lorenzo, Giuseppe
    Buonerba, Carlo
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (13) : 1817 - 1819
  • [39] Targeted therapy in combination with gemcitabine in non-small cell lung cancer
    Rosell, R
    Crino, L
    Danenberg, K
    Scagliotti, G
    Bepler, G
    Taron, M
    Alberola, V
    Provencio, M
    Camps, C
    De Marinis, F
    Sanchez, JJ
    Peñas, R
    SEMINARS IN ONCOLOGY, 2003, 30 (04) : 19 - 25
  • [40] Targeted Therapy and Immunotherapy in the Treatment of Non-Small Cell Lung Cancer
    Shroff, Girish S.
    de Groot, Patricia M.
    Papadimitrakopoulou, Vassiliki A.
    Truong, Mylene T.
    Carter, Brett W.
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2018, 56 (03) : 485 - +
12345